Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3699645010 | Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3699647019 | Drospirenone 3 mg and ethinylestradiol 30 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3699648012 | Drospirenone 3 mg and ethinyl estradiol 30 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Plays role | Contraceptive therapeutic role (role) | true | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ethinyl estradiol | true | Inferred relationship | Some | 1 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | microgram (qualifier value) | true | Inferred relationship | Some | 1 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Drospirenone (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | éthinylestradiol | false | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Ethinyl estradiol | false | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Estradiol | false | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing drospirenone (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Drospirenone (substance) | false | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing drospirenone and ethinylestradiol (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Progesterone | false | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing estradiol in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Ethinyl estradiol | false | Inferred relationship | Some | 1 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Ethinyl estradiol | true | Inferred relationship | Some | 1 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 0.03 (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Drospirenone (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Drospirenone (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | trois | false | Inferred relationship | Some | 2 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Drospirenone (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | trois | false | Inferred relationship | Some | 1 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Ethinyl estradiol | false | Inferred relationship | Some | 2 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing drospirenone and ethinylestradiol in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Drospirenone (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ethinyl estradiol | false | Inferred relationship | Some | 2 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | microgram (qualifier value) | false | Inferred relationship | Some | 2 | |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 30 (qualifier value) | false | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)